http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA#Head
http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA#assertion
http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA#provenance
http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA#pubinfo
http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA#assertion
http://purl.obolibrary.org/obo/DOID_14654
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_14654
http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB00567
http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA#association
http://www.w3.org/2000/01/rdf-schema#label
cephalexin is a cephalosporin antibacterial drug indicated for the treatment of the following infections caused by susceptible isolates of designated bacteria respiratory tract infection 1 1 otitis media 1 2 skin and skin structure infections 1 3 bone infections 1 4 genitourinary tract infections 1 5 to reduce the development of drug resistant bacteria and maintain the effectiveness of cephalexin capsules cephalexin for oral suspension and cephalexin tablets and other antibacterial drugs cephalexin capsules cephalexin for oral suspension and cephalexin tablets should be used only to treat infections that are proven or strongly suspected to be caused by bacteria 1 6 cephalexin is indicated for the treatment of respiratory tract infections caused by susceptible isolates of streptococcus pneumoniae streptococcus pyogenes cephalexin is indicated for the treatment of otitis media caused by susceptible isolates of streptococcus pneumoniae haemophilus influenzae staphylococcus aureus streptococcus pyogenes moraxella catarrhalis cephalexin is indicated for the treatment of skin and skin structure infections caused by susceptible isolates of the following gram positive bacteria staphylococcus aureus streptococcus pyogenes cephalexin is indicated for the treatment of bone infections caused by susceptible isolates of staphylococcus aureus proteus mirabilis cephalexin is indicated for the treatment of genitourinary tract infections including acute prostatitis caused by susceptible isolates of escherichia coli proteus mirabilis klebsiella pneumoniae to reduce the development of drug resistant bacteria and maintain the effectiveness of cephalexin capsules cephalexin for oral suspension and cephalexin tablets and other antibacterial drugs cephalexin capsules cephalexin for oral suspension and cephalexin tablets should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria when culture and susceptibility information is available this information should be considered in selecting or modifying antibacterial therapy in the absence of such data local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy
http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA#association
https://w3id.org/biolink/vocab/relation
https://schema.org/TreatmentIndication
https://identifiers.org/drugbank:DB00567
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA#provenance
http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA#pubinfo
http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA#sig
http://purl.org/nanopub/x/hasSignature
BcTRu5VM9adT5/mHKquzCS6sBBa0uOtDI0Wv5nleAPRXKQtPDrLsg5A4BUWKUhHMjAqhnweHAAp3JC+/78+LPZe5daB/3Qtp6ZMqgawQQdKXjiMluMAyqukYzIsSQHzVYAbeUTI7bSJgyIJs741zBy46xWl3EC1kzV/6UF6mt4A=
http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA
http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA
http://purl.org/dc/terms/created
2021-06-13T15:56:39.798+02:00
http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAhjWiKNT3Mt-gbw-nRdwMpy6C5dM21O2dcnR1ZTInSvA
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs